GH
Greg Harrison Scotiabank Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
United Therapeutics
UTHR
$17.2B
| $380.47 | $463 |
22%
upside
| Neutral | 2 days ago |
|
2
Mineralys Therapeutics
MLYS
$2.2B
| $33.12 | $43 |
30%
upside
| Buy | 7 days ago |
|
3
Travere Therapeutics
TVTX
$1.89B
| $21.15 | $31 |
47%
upside
| Sector Outperform | 28 days ago |
|
4
Ocular Therapeutix
OCUL
$2.21B
| $12.70 | $20 |
57%
upside
| Sector Outperform | 29 days ago |
|
5
BridgeBio Pharma
BBIO
$9.91B
| $51.83 | $57 |
10%
upside
| Sector Outperform | 29 days ago |
|
6
Vertex Pharmaceuticals
VRTX
$102B
| $396.93 | $438 |
10%
upside
| Sector Perform | 1 month ago |
|
7
Alnylam Pharmaceuticals
ALNY
$59.4B
| $453.54 | $450 |
1%
downside
| Sector Outperform | 1 month ago |
|
8
Agios Pharmaceuticals
AGIO
$2.1B
| $36.13 | $65 |
80%
upside
| Sector Outperform | 1 month ago |
|
9
Rocket Pharmaceuticals
RCKT
$349M
| $3.23 | $4 |
24%
upside
| Neutral | 1 month ago |
|
|
10
Agios Pharmaceuticals
AGIO
$2.1B
| $36.13 | $51 |
41%
upside
| Buy | 1 month ago |
|
11
Gossamer Bio
GOSS
$571M
| $2.51 | $11 |
338%
upside
| Sector Outperform | 1 month ago |
|
12
Arcturus Therapeutics
ARCT
$455M
| $16.76 | $35 |
109%
upside
| Sector Outperform | 2 months ago |
|
13
Vera Therapeutics
VERA
$1.4B
| $21.90 | $55 |
151%
upside
| Sector Outperform | 3 months ago |
|
|
14
Rocket Pharmaceuticals
RCKT
$349M
| $3.23 | $19 |
488%
upside
| Sector Outperform | 3 months ago |
|
15
Liquidia Corp
LQDA
$2.48B
| $28.84 | $37 |
28%
upside
| Sector Outperform | 3 months ago |
|
16
Keros Therapeutics
KROS
$632M
| $15.55 | $26 |
67%
upside
| Sector Outperform | 3 months ago |
|
17
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $20 |
30%
downside
| Sector Perform | 3 months ago |
|
18
Geron
GERN
$880M
| $1.38 | $1.50 |
9%
upside
| Sector Perform | 3 months ago |
|
19
Beam Therapeutics
BEAM
$1.88B
| $18.54 | $40 |
116%
upside
| Sector Outperform | 5 months ago |
|
20
Disc Medicine
IRON
$2.09B
| $60.19 | $75 |
25%
upside
| Sector Outperform | 6 months ago |
|
|
21
Keros Therapeutics
KROS
$632M
| $15.55 | $77 |
395%
upside
| Buy | 9 months ago |
|
22
EyePoint Pharmaceuticals
EYPT
$819M
| $11.88 | $18 |
52%
upside
| Sector Outperform | 10 months ago |
|
|
23
Liquidia Corp
LQDA
$2.48B
| $28.84 | $15 |
48%
downside
| Buy | 1 year ago |
|
|
24
Beam Therapeutics
BEAM
$1.88B
| $18.54 | $35 |
89%
upside
| Neutral | 1 year ago |
|
|
25
Travere Therapeutics
TVTX
$1.89B
| $21.15 | $27 |
28%
upside
| Buy | 1 year ago |
|